|
1
|
Arbyn M, Weiderpass E, Bruni L, de Sanjose
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang J, Zhao Y, Dai Y, Dang L, Ma L, Yang
C, Li Y, Kong L, Wei L, Zhang S, et al: Effectiveness of High-risk
human papillomavirus testing for cervical cancer screening in
China: A multicenter, open-label, randomized clinical trial. JAMA
Oncol. 7:263–270. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrall L, Lin KY, Roden RBS, Hung CF and
Wu TC: Cervical cancer immunotherapy: Facts and Hopes. Clin Cancer
Res. 27:4953–4973. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li Y, Li S and Huang L: Knockdown of
Rap2B, a Ras superfamily protein, inhibits proliferation,
migration, and invasion in cervical cancer cells via regulating the
ERK1/2 signaling pathway. Oncol Res. 26:123–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang H, Chen L, Sun X, Yang Q, Wan L and
Guo C: Matrine: A promising natural product with various
pharmacological activities. Front Pharmacol. 11:5882020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang X, Chen W, Jin Y, Li J and Hu Y:
Effect of Sophora flavescens alkaloid on aerobic vaginitis in gel
form for local treatment. J Tradit Chin Med. 37:314–320. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang W, You RL, Qin WJ, Hai LN, Fang MJ,
Huang GH, Kang RX, Li MH, Qiao YF, Li JW, et al: Anti-tumor
activities of active ingredients in Compound Kushen Injection. Acta
Pharmacol Sin. 36:676–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Lin H and Zhang R: The clinical
efficacy and adverse effects of interferon combined with matrine in
chronic hepatitis B: A systematic review and meta-analysis.
Phytother Res. 31:849–857. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oveissi V, Ram M, Bahramsoltani R,
Ebrahimi F, Rahimi R, Naseri R, Belwal T, Devkota HP, Abbasabadi Z
and Farzaei MH: Medicinal plants and their isolated phytochemicals
for the management of chemotherapy-induced neuropathy: Therapeutic
targets and clinical perspective. Daru. 27:389–406. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun N, Zhang H, Sun P, Khan A, Guo J,
Zheng X, Sun Y, Fan K, Yin W and Li H: Matrine exhibits antiviral
activity in a PRRSV/PCV2 co-infected mouse model. Phytomedicine.
77:1532892020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang J and Wang G: Matrine protects PC12
cells from lipopolysaccharide-evoked inflammatory injury via
upregulation of miR-9. Pharm Biol. 58:314–320. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Cui L, Guan G, Wang J, Qiu C,
Yang T, Guo Y and Liu Z: Matrine suppresses cardiac fibrosis by
inhibiting the TGFβ/Smad pathway in experimental diabetic
cardiomyopathy. Mol Med Rep. 17:1775–1781. 2018.PubMed/NCBI
|
|
13
|
Luo Y, Zhang G, Liu X, Yuan M, Gao Q, Gao
H, Ke L, Zhang X, Shi Y, Ma X, et al: Therapeutic and
immunoregulatory effects of water-soluble alkaloids E2-a from
Sophora moorcroftiana seeds as a novel potential agent against
echinococcosis in experimentally protoscolex-infected mice. Vet
Res. 49:1002018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Zhang H, Zhu Z, Jiang L, Lu X,
Zhou M, Sun X, He L, Bai Y and Ma L: Matrine regulates immune
functions to inhibit the proliferation of leukemic cells. Int J
Clin Exp Med. 8:5591–5600. 2015.PubMed/NCBI
|
|
15
|
Wang JK, Zhao BS, Wang M, Liu CY, Li YQ,
Ma QT, Li PF, Wang TS, Wang CG and Zhou YM: Anti-tumor and
phenotypic regulation effect of Matrine on dendritic cells through
regulating TLRs pathway. Chin J Integr Med. 27:520–526. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu G, Cao C, Deng Z, Li J, Zhou X, Huang Z
and Cen C: Effects of matrine in combination with cisplatin on
liver cancer. Oncol Lett. 21:662021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gu C, Lu H and Qian Z: Matrine reduces the
secretion of exosomal circSLC7A6 from cancer-associated fibroblast
to inhibit tumorigenesis of colorectal cancer by regulating CXCR5.
Biochem Biophys Res Commun. 527:638–645. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liang X and Ju J: Matrine inhibits ovarian
cancer cell viability and promotes apoptosis by regulating the
ERK/JNK signaling pathway via p38MAPK. Oncol Rep. 45:822021.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu X, Zhou J, Cai D and Li M: Matrine
inhibits the metastatic properties of human cervical cancer cells
via downregulating the p38 signaling pathway. Oncol Rep.
38:1312–1320. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Zhang J, Ma H, Chen X, Liu T, Jiao
Z, He W, Wang F, Liu X and Zeng X: Protective role of autophagy in
matrineinduced gastric cancer cell death. Int J Oncol.
42:1417–1426. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liao XZ, Tao LT, Liu JH, Gu YY, Xie J,
Chen Y, Lin MG, Liu TL, Wang DM, Guo HY and Mo SL: Matrine combined
with cisplatin synergistically inhibited urothelial bladder cancer
cells via down-regulating VEGF/PI3K/Akt signaling pathway. Cancer
Cell Int. 17:1242017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Q, Xu J, He Z, Wen X, Wang F, Zhang P,
Li J, Song B, Wang Q, Li R and Huang H: The effects of Matrine in
combination with docetaxel on castration-resistant
(Androgen-independent) prostate cancer. Cancer Manag Res.
11:10125–10133. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou H, Chen S, Yang Y, Yang C, Chen D,
Yao Z and Sun B: Matrine enhances the efficacy of adriamycin
chemotherapy in osteosarcoma cells by the STAT3 pathway. Anticancer
Drugs. 30:1006–1012. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang RK and Wang C: Effect of matrine on
tumor growth and inflammatory factors and immune function in Wistar
rat with breast cancer. Zhongguo Ying Yong Sheng Li Xue Za Zhi.
34:375–378. 2018.(In Chinese). PubMed/NCBI
|
|
25
|
Sun X, Shu Y, Xu M, Jiang J, Wang L, Wang
J, Huang D and Zhang J: ANXA6 suppresses the tumorigenesis of
cervical cancer through autophagy induction. Clin Transl Med.
10:e2082020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu MY, Wang SF, Cai CZ, Tan JQ, Li M, Lu
JJ, Chen XP, Wang YT, Zheng W and Lu JH: Natural autophagy
blockers, dauricine (DAC) and daurisoline (DAS), sensitize cancer
cells to camptothecin-induced toxicity. Oncotarget. 8:77673–77684.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cho YR, Lee JH, Kim JH, Lee SY, Yoo S,
Jung MK, Kim SJ, Yoo HJ, Pack CG, Rho JK and Son J: Matrine
suppresses KRAS-driven pancreatic cancer growth by inhibiting
autophagy-mediated energy metabolism. Mol Oncol. 12:1203–1215.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie SB, He XX and Yao SK: Matrine-induced
autophagy regulated by p53 through AMP-activated protein kinase in
human hepatoma cells. Int J Oncol. 47:517–526. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chi G, Xu D, Zhang B and Yang F: Matrine
induces apoptosis and autophagy of glioma cell line U251 by
regulation of circRNA-104075/BCL-9. Chem Biol Interact.
308:198–205. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Peng X, Zhou D, Wang X, Hu Z, Yan Y and
Huang J: Matrine suppresses proliferation and invasion of SGC7901
cells through inactivation of PI3K/Akt/uPA pathway. Ann Clin Lab
Sci. 46:457–462. 2016.PubMed/NCBI
|
|
31
|
Yu L, Zhou Y, Yang Y, Lu F and Fan Y:
Efficacy and safety of Compound Kushen Injection on patients with
advanced colon cancer: A meta-analysis of randomized controlled
trials. Evid Based Complement Alternat Med. 2017:71025142017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Prodromidou A, Iavazzo C, Fotiou A,
Psomiadou V, Douligeris A, Vorgias G and Kalinoglou N: Short- and
long term outcomes after abdominal radical trachelectomy versus
radical hysterectomy for early stage cervical cancer: A systematic
review of the literature and meta-analysis. Arch Gynecol Obstet.
300:25–31. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schuurman T, Zilver S, Samuels S, Schats
W, Amant F, van Trommel N and Lok C: Fertility-sparing surgery in
gynecologic cancer: A systematic review. Cancers (Basel).
13:10082021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Naga CP, Gurram L, Chopra S and
Mahantshetty U: The management of locally advanced cervical cancer.
Curr Opin Oncol. 30:323–329. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lorusso D, Petrelli F, Coinu A,
Raspagliesi F and Barni S: A systematic review comparing cisplatin
and carboplatin plus paclitaxel-based chemotherapy for recurrent or
metastatic cervical cancer. Gynecol Oncol. 133:117–123. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang HQ, Jin JJ and Wang J: Matrine
induces mitochondrial apoptosis in cisplatin-resistant non-small
cell lung cancer cells via suppression of β-catenin/survivin
signaling. Oncol Rep. 33:2561–2566. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li L, Xue T, Xu W and Zhou B: Effect of
matrine combined with cisplatin on the expression of XIAP in human
rhabdomyosarcoma RD cells. Oncol Lett. 12:3793–3798. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xia J, Yu X, Song X, Li G, Mao X and Zhang
Y: Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin
resistance in human cervical cancer cells. Mol Med Rep. 15:488–494.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen M, Ding Y and Tong Z: Efficacy and
safety of Sophora flavescens (Kushen) based traditional Chinese
medicine in the treatment of ulcerative colitis: Clinical evidence
and potential mechanisms. Front Pharmacol. 11:6034762020.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen Y, Chen LM, Tong Y and You Y:
Pharmacological effect and toxicology of Sophorae Tonkinensis Radix
et Rhizoma. Zhongguo Zhong Yao Za Zhi. 42:2439–2442. 2017.(In
Chinese). PubMed/NCBI
|
|
43
|
Yang MW, Chen F, Zhu DJ, Li JZ, Zhu JL,
Zeng W, Qu SL and Zhang Y: Clinical efficacy of Matrine and Sodium
Chloride Injection in treatment of 40 cases of COVID-19. Zhongguo
Zhong Yao Za Zhi. 45:2221–2231. 2020.(In Chinese). PubMed/NCBI
|
|
44
|
He R, Ou S, Chen S and Ding S: Network
pharmacology-based study on the molecular biological mechanism of
action for Compound Kushen Injection in anti-cancer effect. Med Sci
Monit. 26:e9185202020. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ao M, Xiao X and Li Q: Efficacy and safety
of compound Kushen injection combined with chemotherapy on
postoperative Patients with breast cancer: A meta-analysis of
randomized controlled trials. Medicine (Baltimore). 98:e140242019.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang GL, Jiang L, Yan Q, Liu RH and Zhang
L: Anti-tumor effect of matrine combined with cisplatin on rat
models of cervical cancer. Asian Pac J Trop Med. 8:1055–1059. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Onorati AV, Dyczynski M, Ojha R and
Amaravadi RK: Targeting autophagy in cancer. Cancer. 124:3307–3318.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Levy JMM, Towers CG and Thorburn A:
Targeting autophagy in cancer. Nat Rev Cancer. 17:528–542. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Amaravadi RK, Kimmelman AC and Debnath J:
Targeting autophagy in cancer: Recent advances and future
directions. Cancer Discov. 9:1167–1181. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wan Q, Du Z, Fang Z, Cheng H, Li C and
Zhou X: Matrine induces apoptosis and autophagy in human lung
adenocarcinoma cells via upregulation of Cavin3 and suppression of
PI3K/AKT pathway. J BUON. 25:1512–1516. 2020.PubMed/NCBI
|
|
51
|
Lin S, Zhuang J, Zhu L and Jiang Z:
Matrine inhibits cell growth, migration, invasion and promotes
autophagy in hepatocellular carcinoma by regulation of
circ_0027345/miR-345-5p/HOXD3 axis. Cancer Cell Int. 20:2462020.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Du J, Li J, Song D, Li Q and Li L, Li B
and Li L: Matrine exerts antibreast cancer activity by mediating
apoptosis and protective autophagy via the AKT/mTOR pathway in MCF7
cells. Mol Med Rep. 22:3659–3666. 2020.PubMed/NCBI
|
|
53
|
Heras-Sandoval D, Perez-Rojas JM,
Hernandez-Damian J and Pedraza-Chaverri J: The role of
PI3K/AKT/mTOR pathway in the modulation of autophagy and the
clearance of protein aggregates in neurodegeneration. Cell Signal.
26:2694–2701. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Aoki M and Fujishita T: Oncogenic roles of
the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 407:153–189.
2017.PubMed/NCBI
|
|
55
|
Xu Z, Han X, Ou D, Liu T, Li Z, Jiang G,
Liu J and Zhang J: Targeting PI3K/AKT/mTOR-mediated autophagy for
tumor therapy. Appl Microbiol Biotechnol. 104:575–587. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Valvezan AJ and Manning BD: Molecular
logic of mTORC1 signalling as a metabolic rheostat. Nat Metab.
1:321–333. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Surviladze Z, Sterk RT, DeHaro SA and
Ozbun MA: Cellular entry of human papillomavirus type 16 involves
activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway
and inhibition of autophagy. J Virol. 87:2508–2517. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang B, Song Y, Sun S, Han R, Hua C, van
der Veen S and Cheng H: Human papillomavirus 11 early protein E6
activates autophagy by repressing AKT/mTOR and Erk/mTOR. J Virol.
93:e00172–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Mattoscio D, Medda A and Chiocca S: Human
papilloma virus and autophagy. Int J Mol Sci. 19:17752018.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhang X, Hou G, Liu A, Xu H, Guan Y, Wu Y,
Deng J and Cao X: Matrine inhibits the development and progression
of ovarian cancer by repressing cancer associated phosphorylation
signaling pathways. Cell Death Dis. 10:7702019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wu J, Hu G, Dong Y, Ma R, Yu Z, Jiang S,
Han Y, Yu K and Zhang S: Matrine induces Akt/mTOR signalling
inhibition-mediated autophagy and apoptosis in acute myeloid
leukaemia cells. J Cell Mol Med. 21:1171–1181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Hao Y, Yin H, Zhu C, Li F, Zhang Y, Li Y,
Wang X and Li D: Matrine inhibits proliferation and promotes
autophagy and apoptosis in non-small cell lung cancer cells by
deactivating PI3K/AKT/mTOR pathway. Nan Fang Yi Ke Da Xue Xue Bao.
39:760–765. 2019.(In Chinese). PubMed/NCBI
|
